BBV154 (intranasal COVID-19 vaccine), preclinical testing has been completed for toxicology, immunogenicity and challenge studies. These studies have been conducted in the USA and India Representational image. ANI Buoyed by …
trials
-
-
India’s Commonwealth Games champion Sanjeev Rajput stamped his authority in the men’s 50m rifle 3p, winning the first selection trials here at the Dr Karni Singh Shooting Ranges on Thursday. …
-
Ecuador’s ambassador to India Hector Cueva Jacome has expressed his confidence in Indian COVID vaccines, highlighting that are ‘part of the solution’. He himself was part of phase-3 trials of …
-
Sanjeev Rajput wins 50m Rifle: Senior Men’s 3-Positions (3P) rifle shooter and double Olympian Sanjeev Rajput showed good form by shooting competitively for the first time since the coronavirus induced …
-
Covaxin has been developed by Hyderabad-based Bharat Biotech. (File photo) In a message posted on the company’s Twitter account, she thanked clinical trial sites, principal investigators and health workers for …
- News
Carried out 200% honest trials, don’t deserve this backlash: Bharat Biotech hits back at critics
Coming down heavily on critics expressing doubts about the Bharat Biotech’s indigenously developed coronavirus vaccine Covaxin, the Hyderabad-based biotech major’s managing director Dr Krishna Ella on Monday slammed the critics …
- News
News18 Daybreak | ‘Carried Out 200% Honest Trials’: Bharat Biotech Top Boss on Critics ‘Bashing’ Covaxin, Govt to Hold Talks With Farmers Again and Other Stories You Need to Watch Out For
Jan 05, 2021 08:21 AM IST Daybreak ‘Won’t Hurt Anyone, Carried Out 200% Honest Trials’: Bharat Biotech Top Boss on Critics ‘Bashing’ Covaxin Amid questions raised by industry experts and …
- News
Shashi Tharoor critcises Centre for giving nod to Bharat Biotech vaccine without phase 3 trials
Congress leader Shashi Tharoor has criticised the government for giving the nod to Bharat Biotech’s COVID-19 vaccine without phase-3 trials. The central licensing authority has granted permission to Bharat Biotech …
- News
Covaxin trials conducted with ‘200% honesty’, says Bharat Biotech MD; new COVID-19 cases under 20,000 for 3rd day – Health News , Firstpost
The global efforts to curb the spread of COVID-19 got a boost in the UK, as it became the first country to administer a vaccine against the virus Hitting out …
-
The Drugs Controller General of India (DCGI) has approved conducting phase III trials of the country’s first DNA vaccine candidate against COVID-19 being developed by Zydus Cadila, the Department of …
-
Hyderabad: Bharat Biotech has successfully recruited 23,000 volunteers, and continued progress towards achieving the goal of 26,000 participants for Phase-3 clinical trial of its COVID-19 vaccine Covaxin across multiple sites …
- News
Coronavirus News LIVE Updates: Bharat Biotech recruits 26,000 volunteers for Phase 3 COVAXIN trials which began November 2020 – India News , Firstpost
Coronavirus News LIVE Updates: The company’s chairman Dr Krishna Ella called DGCI’s approval for COVAXIN ‘a giant leap for innovation and novel product development in India’ Coronavirus News LATEST Updates: Expressing …
- General
UK scientists begin trials of instant immunity antibody drug treatment for COVID-19 – World News , Firstpost
The researchers said that through the study, they ‘hope to find that giving this treatment via injection can lead to immediate protection against the development of COVID-19 in people’ Representational …
- News
Grant Emergency Authorisation to Covid Vaccines Only After Enough Trials: Parl Committee Warns Govt
On the eve of India getting it’s first COVID-19 vaccine, Parliamentary Standing Committee on Home Affairs has warned the government against rushing through authorisation. The Anand Sharma-led committee, in its …
- News
Coronavirus live updates | Over 100 experts from friendly nations trained for clinical trials of Indian vaccine
The interim findings from the phase-1 placebo-controlled randomised double-blind trial on the safety and immunogenicity of three different formulations of BBV152 reported the results of the trial on 375 participants, …
- News
Over 100 Experts from Friendly Nations Trained for Clinical Trials of Indian Covid-19 Vaccine: Official
Over 100 experts from friendly neighbouring nations have so far been trained to strengthen capacities in their countries for facilitating phase-3 clinical trials of Indian COVID-19 vaccine, a senior official …
- News
Covaxin produces ‘robust’ antibody response with no serious adverse events, Phase 1 trials show – Health News , Firstpost
The findings have appeared on medRxiv, a preprint server. A preprint is a version of a scientific manuscript posted on a public server prior to formal peer review COVAXIN vaccine …
-
Written by Prabha Raghavan | New Delhi | December 15, 2020 2:13:49 am Covid testing in New Delhi on Monday. (Express photo by Praveen Khanna) Pune-based Gennova Biopharmaceuticals plans to …
-
Cody Simpson, the pop singer and Broadway actor, qualified for Australia’s Olympic swim trials just months after breaking up with Miley Cyrus. “I just qualified for my first Olympic trials,” …
- General
Oxford-AstraZeneca Covid-19 Vaccine to be Combined With Russia’s Sputnik Shot in ‘Mix-Match’ Trials
Pharmaceutical giant AstraZeneca’s Russian branch said Friday it would use part of Russia’s homemade Sputnik V vaccine in further clinical trials, a major sign of recognition for a jab that …
-
Peru has temporarily suspended clinical trials of a Covid vaccine made by Chinese drug giant Sinopharm after detecting neurological problems in one of its test volunteers. The National Institute of …
-
The United Arab Emirates said on Wednesday that it approved a Chinese coronavirus vaccine that is being tested in the country after preliminary data showed that it was 86 percent …
- News
CSIR to decide on human clinical trials of Molnupiravir –– a drug that blocks SARS-CoV-2 in 24 hours
Written by Anuradha Mascarenhas | Pune | Updated: December 7, 2020 12:06:50 pm According to the researchers, Molnupiravir is the first oral anti-viral drug to quickly block SARS-CoV 2. (Representational …
-
The phase 2 human trial of Russian vaccine Sputnik V began at a Pune hospital with 17 volunteers being administered the first dose of vaccine. The first dose of the …
- General
Results of COVID-19 vaccine trials show world can dream of pandemic’s end: WHO chief – World News , Firstpost
The chief of the global health body also warned that the rich and powerful countries must not trample the poor and marginalized ‘in the stampede for vaccines’ United Nations: The …
- News
Second COVID-19 wave may hit Karnataka in early 2021; Covaxin phase 3 trials begin in Bengal, UK approves Pfizer jab – Health News , Firstpost
Meanwhile, world leaders, including the top leadership of the UN and vaccine developers, will address a two-day, special session of the UN General Assembly on COVID-19 this week Karnataka is …